BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 27, 2012
View Archived Issues
New inhibitors of V600E-mutant B-raf presented
Read More
Chugai presents new highly potent and selective AXL inhibitor
Read More
Pozen discusses FDA meeting on integrated aspirin therapy NDA
Read More
Bristol-Myers Squibb halts development of candidate hepatitis drug
Read More
JAK inhibitor reduces signs and symptoms of arthritis in phase III trials
Read More
Novel PET tracer for tau imaging shows promise in vivo
Read More
Zyclara approved in Europe
Read More
Updated results from EMILIA study of trastuzumab emtansine
Read More
Novartis reports new mTOR/PI3K inhibitors
Read More
Collaborating organizations in France design new candidate drugs for parasitic diseases
Read More
Novel beta1-adrenoceptor ligands developed in U.K.
Read More
FDA issues refuse to file letter for Lemtrada sBLA
Read More
New everolimus formulation approved in Japan
Read More
Data reported from TRILOGY ACS trial of prasugrel
Read More
Abbott presents discovery of multiple HCV NS5B inhibitors
Read More
Seattle Genetics kicks off new study in renal cell carcinoma
Read More
Ten-gene molecular signature predicts response to cancer radiotherapy
Read More
Baxter to discontinue manufacturing Gammagard product
Read More
Plavix approved for STEMI in Japan
Read More
Lilly reports topline phase III results in Alzheimer's disease
Read More
NICE issues draft guidance on product for stroke
Read More
GSK and Theravance complete phase III COPD program
Read More
Strattera approved in Japan for adult ADHD
Read More